LPL Financial Portfolio holdings
LPL Financial, founded in 1989 through the merger of Linsco and Private Ledger and headquartered in San Diego, California, is the largest independent broker-dealer in the U.S., supporting over 22,000 financial advisors who manage more than $1.4 trillion in advisory and brokerage assets as of late 2024. Serving independent advisors, banks, and credit unions, LPL provides a robust technology platform, research, and back-office support, enabling advisors to offer personalized wealth management, retirement planning, and investment services to clients without proprietary products. The firm, publicly traded since 2010 under CEO Dan Arnold, has grown through acquisitions like Waddell & Reed’s wealth management business in 2021, emphasizing flexibility and advisor autonomy. With additional offices in Fort Mill, South Carolina, and Boston, LPL Financial remains a leader in empowering advisors amid a shifting financial landscape.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$693M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$529M |
| 3 |
iShares MSCI USA Quality Factor ETF
QUAL
|
$381M |
| 4 |
iShares MSCI EAFE Growth ETF
EFG
|
$278M |
| 5 |
Apple
AAPL
|
$276M |
Top Sells
Sector Composition
| 1 | Technology | 8.27% |
| 2 | Financials | 3.61% |
| 3 | Consumer Discretionary | 2.98% |
| 4 | Healthcare | 2.45% |
| 5 | Industrials | 2.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IAE
4901
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$76.9M
| $83.1K | ﹤0.01% |
13,711
+97
| +0.7% | +$588 |
|
4902
Evolution Petroleum
EPM
$174M
| $82.9K | ﹤0.01% |
15,848
+4,955
| +45% | +$25.9K |
|
|
DHC
4903
Diversified Healthcare Trust
DHC
$995M
| $82.4K | ﹤0.01% |
35,836
+2,189
| +7% | +$5.04K |
|
|
CCIF
4904
Carlyle Credit Income Fund
CCIF
$120M
| $82.1K | ﹤0.01% |
+10,337
| New | +$82.1K |
|
4905
Broadwind
BWEN
$47.2M
| $82K | ﹤0.01% |
43,628
-8,572
| -16% | -$16.1K |
|
4906
loanDepot
LDI
$605M
| $81.7K | ﹤0.01% |
40,035
+11,286
| +39% | +$23K |
|
4907
Puma Biotechnology
PBYI
$253M
| $81K | ﹤0.01% |
26,567
+5,080
| +24% | +$15.5K |
|
4908
Akebia Therapeutics
AKBA
$785M
| $81K | ﹤0.01% |
42,638
-1,497
| -3% | -$2.84K |
|
|
NXDT
4909
NexPoint Diversified Real Estate Trust
NXDT
$180M
| $80.1K | ﹤0.01% |
13,127
-1,124
| -8% | -$6.86K |
|
|
ACCD
4910
DELISTED
Accolade, Inc. Common Stock
ACCD
| $79.3K | ﹤0.01% |
23,201
+1,912
| +9% | +$6.54K |
|
|
TSI
4911
TCW Strategic Income Fund
TSI
$238M
| $79.2K | ﹤0.01% |
16,473
+382
| +2% | +$1.84K |
|
|
RGLS
4912
DELISTED
Regulus Therapeutics
RGLS
| $79K | ﹤0.01% |
49,980
-8,000
| -14% | -$12.6K |
|
4913
Seres Therapeutics
MCRB
$169M
| $78.8K | ﹤0.01% |
4,739
-1,372
| -22% | -$22.8K |
|
4914
Dyadic International
DYAI
$32.9M
| $78.6K | ﹤0.01% |
44,887
-3,000
| -6% | -$5.25K |
|
4915
Ring Energy
REI
$207M
| $77.6K | ﹤0.01% |
57,038
| – | – |
|
|
SACH
4916
Sachem Capital Corp
SACH
$59.7M
| $77.5K | ﹤0.01% |
57,394
-7,468
| -12% | -$10.1K |
|
4917
Blue Ridge Bankshares
BRBS
$374M
| $77.5K | ﹤0.01% |
24,060
+13,339
| +124% | +$43K |
|
4918
Gevo
GEVO
$404M
| $77K | ﹤0.01% |
36,853
+2,182
| +6% | +$4.56K |
|
|
CIF
4919
MFS Intermediate High Income Fund
CIF
$31.3M
| $76.6K | ﹤0.01% |
44,305
-2,375
| -5% | -$4.11K |
|
|
PCK
4920
DELISTED
Pimco California Municipal Income Fund II
PCK
| $76.3K | ﹤0.01% |
13,331
-8,436
| -39% | -$48.3K |
|
4921
SCYNEXIS
SCYX
$37.3M
| $75.5K | ﹤0.01% |
62,380
-13,150
| -17% | -$15.9K |
|
4922
Beyond Meat
BYND
$189M
| $75.4K | ﹤0.01% |
20,065
-1,979
| -9% | -$7.44K |
|
|
IMMP
4923
Immutep
IMMP
$242M
| $74.9K | ﹤0.01% |
34,532
+3,200
| +10% | +$6.94K |
|
|
TVRD
4924
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $74.8K | ﹤0.01% |
4,073
-67
| -2% | -$1.23K |
|
4925
TrueCar
TRUE
$191M
| $74.6K | ﹤0.01% |
20,000
-20,000
| -50% | -$74.6K |
|